Literature DB >> 27020907

Prevalence, Severity, and Prognostic Effect of Hepatopulmonary Syndrome in Liver Transplant Candidates.

Abdullah Al-Harbi1, Khalid Abdullah2, Abdulmajeed Al-Abdulkareem2, Ali Alghamdi3, Hamdan Al-Jahdali1.   

Abstract

BACKGROUND: Hepatopulmonary syndrome (HPS) is commonly encountered in the setting of end-stage liver disease (ESLD). Past studies have reported conflicting results in terms of demonstrating an association between HPS and mortality. The aim of this study was to determine the prevalence of HPS in patients with ESLD referred for assessment of transplantation suitability. In addition, we investigated survival rates in the setting of HPS, with and without liver transplantation.
MATERIAL AND METHODS: The medical records of 524 consecutive patients with ESLD evaluated for potential liver transplantation were retrospectively reviewed. HPS was defined by a reduced partial pressure of oxygen or an elevated alveolar-arterial oxygen gradient and the presence of intrapulmonary vascular dilatation on contrast-enhanced echocardiography.
RESULTS: In total, 57 subjects (12%) fulfilled the diagnostic criteria of HPS; 88% of these had mild to moderate HPS. For patients with HPS, the overall survival rates at 1 and 3 years were 95% and 92%, respectively. Liver transplants were received by 245 patients (53%), 26 of whom had HPS. For transplant recipients with HPS, the overall survival rates at 1 and 3 years were 96% and 91%, respectively, compared to 85% and 80% in subjects without HPS. Post-transplantation survival in patients with and without HPS did not differ significantly (HR=0.489, 95% CI: 0.153-1.564; p=0.228).
CONCLUSIONS: This study demonstrated a high prevalence of IPVD and HPS among patients who were potential candidates for liver transplantation. HPS was mild to moderate in the majority of those affected and had no significant effect on overall survival.

Entities:  

Mesh:

Year:  2016        PMID: 27020907     DOI: 10.12659/aot.896095

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  4 in total

1.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation.

Authors:  Kelley Weinfurtner; Kimberly Forde
Journal:  Curr Hepatol Rep       Date:  2020-07-11

2.  Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis.

Authors:  Stergios Soulaidopoulos; Ioannis Goulis; George Giannakoulas; Theofilos Panagiotidis; Petros Doumtsis; Areti Karasmani; Theodora Oikonomou; Theodora Tzoumari; Haralampos Karvounis; Εvangelos Cholongitas
Journal:  Ann Gastroenterol       Date:  2016-12-22

Review 3.  Review article: Update on current and emergent data on hepatopulmonary syndrome.

Authors:  Stergios Soulaidopoulos; Evangelos Cholongitas; George Giannakoulas; Maria Vlachou; Ioannis Goulis
Journal:  World J Gastroenterol       Date:  2018-03-28       Impact factor: 5.742

4.  Chronic Hepatitis C with Cyanosis.

Authors:  Mahmood Alawainati; Jawad Khamis; Muneer Abdulla; Saeed Alsaeed
Journal:  Case Reports Hepatol       Date:  2019-01-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.